Wetzel Investment Advisors Inc. Purchases Shares of 500 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wetzel Investment Advisors Inc. purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 500 shares of the exchange traded fund’s stock, valued at approximately $45,000.

A number of other hedge funds have also recently bought and sold shares of XBI. JPMorgan Chase & Co. grew its stake in SPDR S&P Biotech ETF by 179.1% in the first quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock valued at $574,202,000 after purchasing an additional 4,835,071 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of SPDR S&P Biotech ETF by 111.4% during the 2nd quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock worth $12,829,000 after acquiring an additional 1,682,382 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $102,900,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 103.3% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after acquiring an additional 900,000 shares during the period. Finally, Squarepoint Ops LLC bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $34,666,000.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of NYSEARCA XBI opened at $82.83 on Monday. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The stock has a 50 day moving average of $93.52 and a 200-day moving average of $84.41. The company has a market capitalization of $6.43 billion, a P/E ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.